Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Riggs Rory B
Relationship:   Chief Executive Office...
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   3,819,637    

Indirect Shares

   745,498      
Direct Value   $58,585,307    

Indirect Value

   $4,112,746      
Total Shares   4,565,135      
Total Value   $62,698,053      


Fibrogen Inc $486,773 Royalty Pharma Plc $8,748,306 Cibus Inc $49,350,229 Fibrogen Inc $486,773 Royalty Pharma Plc $8,748,306 Cibus Inc $49,350,229
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    30    

     Stock price went up :
    1   
    14    
     Stock price went down :
    2   
    16    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   8.4%
 -171.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Fibrogen Inc FGEN Director 2021-05-26 395,750 2021-05-26 605,713    Premium*  
            Royalty Pharma Plc RPRX Director 2024-02-20 320,099 2024-02-20 100,187    Premium*  
            Cibus Inc CBUS Chief Executive Office... 2023-12-29 3,103,788 2023-12-29 39,598    Premium*  
* Premium Members only  

Records found :    73         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
FGEN Fibrogen Inc Director   –       •      –    2014-11-19 4 A $0.00 $0 D/D 110,000 530,200 0 -
FGEN Fibrogen Inc Director   –       •      –    2014-11-19 4 A $0.00 $0 I/I 233,699 605,713 0 -
FGEN Fibrogen Inc Director   –       •      –    2018-06-05 4 A $0.00 $0 D/D 3,700 382,900 0 -
FGEN Fibrogen Inc Director   –       •      –    2019-06-05 4 A $0.00 $0 D/D 4,700 386,350 0 -
FGEN Fibrogen Inc Director   –       •      –    2020-06-04 4 A $0.00 $0 D/D 4,700 391,050 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2020-06-18 4/A A $0.00 $0 I/I 5,700,080 1,113,010 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2020-10-20 4 A $0.00 $0 D/D 463,200 463,200 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2021-05-07 4 A $0.00 $0 D/D 679,760 679,760 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2021-05-07 4 A $0.00 $0 I/I 2,355,190 2,355,190 0 -
FGEN Fibrogen Inc Director   –       •      –    2021-05-26 4 A $0.00 $0 D/D 4,700 395,750 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2021-09-29 4 A $0.00 $0 D/D 16,274 631,386 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2021-11-16 4 A $0.00 $0 D/D 66,012 697,398 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2021-12-28 4 A $0.00 $0 D/D 45,350 667,748 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2022-03-17 4 A $0.00 $0 D/D 68,964 661,712 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2023-02-17 4 A $0.00 $0 D/D 1,500,000 1,596,712 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2023-05-09 4 A $0.00 $0 D/D 300,000 1,756,762 0 -
CBUS Cibus Inc Chief Executive Officer   •       •       •   2023-05-31 4 A $0.00 $0 I/I 1,658,267 2,888,084 0 -
CBUS Cibus Inc Chief Executive Officer   •       •       •   2023-05-31 4 A $0.00 $0 D/D 2,383,281 1,361,226 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2023-06-23 4 A $0.00 $0 D/D 7,747 14,509 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2023-11-13 4 A $0.00 $0 D/D 475,590 490,099 0 -
CBUS Cibus Inc Chief Executive Officer   •       •       •   2023-12-29 4 A $0.00 $0 D/D 1,500,000 1,367,193 0 -
CBUS Cibus Inc Chief Executive Officer   •       •       •   2023-12-29 4 A $0.00 $0 D/D 1,505,967 2,867,193 0 -
CBUS Cibus Inc Chief Executive Officer   •       •       •   2023-12-29 4 A $0.00 $0 D/D 1,500,000 3,103,788 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2024-02-20 4 A $0.00 $0 D/D 300,000 320,099 0 -
RPRX Royalty Pharma Plc Director   –       •      –    2020-06-18 4 B $28.00 $420,000 I/I 15,000 15,000 2.1 %
  73  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us